Lingling Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lingling Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Huocong He
Laboratory of Radiation Biology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital Fuzhou Fujian China
1 shared publication - Jianru Pan
College of Biological Science and Engineering, Fuzhou University, Fuzhou, China
1 shared publication Lili Liang
College of Biological Science and Engineering, Fuzhou University, No. 2 Xue Yuan Road, University Town, Fuzhou, Fujian 350108, China
1 shared publication- Shutao Liu
Zhicheng College, Fuzhou University, Fuzhou 350002, China
1 shared publication - Xiangling Wang
Cleveland Clinic Foundation, Cleveland, OH, USA
1 shared publication - Ying Su
Laboratory of Radiation Biology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, 350014, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 1 January 2017
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2017 (1) , 9530791
Cytoprotective Effects of Cell‐Permeable Bifunctional Antioxidant Enzyme, GST‐TAT‐SOD, against Cisplatin‐Induced Cell Damage
GST‐TAT‐SOD, a cell‐permeable bifunctional antioxidant enzyme, is a potential selective radioprotector. This study aimed to investigate the cytoprotective activity of GST‐TAT‐SOD against cisplatin‐induced damage. The current study showed that cisplatin induced the formation of reactive oxygen species in normal L‐02 cells. GST‐TAT‐SOD (2000 U/mL) executed its antioxidant role by directly scavenging excess intracellular free radicals and augmenting cellular antioxidant defense such as reducing MDA level, enhancing the SOD activity, GST activity, and T‐AOC. Thus, it suppressed the growth inhibition and apoptosis of cisplatin‐treated normal cells. Meanwhile, the growth inhibition of tumor cells (SMMC‐7721) caused by cisplatin was unaffected by GST‐TAT‐SOD pretreatment. GST‐SOD, as a comparison, seemed to be powerless for related indicators as it could not enter into cells without cell‐permeating peptide. These results suggest that GST‐TAT‐SOD might be a potential cytoprotective agent for cisplatin‐induced side effects.
- 1 January 2017
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2017 (1) , 9530791
Open AccessCytoprotective Effects of Cell‐Permeable Bifunctional Antioxidant Enzyme, GST‐TAT‐SOD, against Cisplatin‐Induced Cell Damage
GST‐TAT‐SOD, a cell‐permeable bifunctional antioxidant enzyme, is a potential selective radioprotector. This study aimed to investigate the cytoprotective activity of GST‐TAT‐SOD against cisplatin‐induced damage. The current study showed that cisplatin induced the formation of reactive oxygen species in normal L‐02 cells. GST‐TAT‐SOD (2000 U/mL) executed its antioxidant role by directly scavenging excess intracellular free radicals and augmenting cellular antioxidant defense such as reducing MDA level, enhancing the SOD activity, GST activity, and T‐AOC. Thus, it suppressed the growth inhibition and apoptosis of cisplatin‐treated normal cells. Meanwhile, the growth inhibition of tumor cells (SMMC‐7721) caused by cisplatin was unaffected by GST‐TAT‐SOD pretreatment. GST‐SOD, as a comparison, seemed to be powerless for related indicators as it could not enter into cells without cell‐permeating peptide. These results suggest that GST‐TAT‐SOD might be a potential cytoprotective agent for cisplatin‐induced side effects.